Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
Filter
  • DKFZ Publication Database  (2,452)
  • PATIENT  (1,580)
  • GENES  (1,104)
Collection
  • Articles  (1)
  • DKFZ Publication Database  (2,452)
Keywords
  • 1
    facet.materialart.
    facet.materialart.
    UNI-MED
    Signatur Availability
    BibTip Others were also interested in ...
  • 2
    Keywords: SYSTEM ; PATIENT ; IMRT ; VERIFICATION ; FLUENCE ; PART
    Type of Publication: Book chapter
    Signatur Availability
    BibTip Others were also interested in ...
  • 3
    Keywords: - ; comparison ; UPSTREAM ; microbiology ; ENGLAND ; technique ; computational biology ; methods ; DNA-MICROARRAY ; GO ; INTERFERENCE ; SCALE ; RNA INTERFERENCE ; EXTENSION ; RE ; FEATURES ; signaling ; German ; in combination ; FALSE DISCOVERY RATE ; SIGNALING NETWORK ; signaling networks ; biotechnology ; RNA ; microarray ; GENES ; DNA ; GENE ; GENE-EXPRESSION ; NETWORK ; NETWORKS ; CELL ; Germany ; CELLS ; EXPRESSION ; CANCER CELLS ; CANCER ; PATHWAYS ; MODEL ; MODELS ; PATHWAY ; human ; COMBINATION ; STABILITY ; bioinformatics ; CANCER-CELLS ; SIGNALING PATHWAYS ; SIGNALING PATHWAY ; EFFICIENT ; RECONSTRUCTION ; BIOLOGY ; INTERVENTION ; BREAST ; breast cancer ; BREAST-CANCER ; gene expression ; MICROARRAY DATA
    Type of Publication: Book chapter
    Signatur Availability
    BibTip Others were also interested in ...
  • 4
    Keywords: CANCER DIAGNOSIS ; THERAPIES ; DNA repair ; methods ; NEW-YORK ; GENE ; GENES ; PATIENT ; CANCER ; CELL ; carcinoma ; radiotherapy ; DIAGNOSIS ; THERAPY ; cell cycle ; CELL-CYCLE ; prognosis ; BREAST ; breast cancer ; BREAST-CANCER ; CANCER-PATIENTS ; side effects ; CANCER PATIENTS
    Type of Publication: Book chapter
    Signatur Availability
    BibTip Others were also interested in ...
  • 5
  • 6
    Keywords: treatment ; ASSOCIATION ; polymorphism ; POLYMORPHISMS ; single nucleotide polymorphism ; SUSCEPTIBILITY ; VARIANTS ; SKIN ; mechanisms ; prevention ; HEALTH ; PROMOTER ; BREAST ; breast cancer ; BREAST-CANCER ; cancer prevention ; smoking ; SNP ; REPAIR ; WOMEN ; LYMPHOCYTES ; DAMAGE ; GENOTYPES ; cancer risk ; CANCER-PATIENTS ; INDIVIDUALS ; case-control studies ; DNA-DAMAGE ; CANCER PATIENTS ; SUSCEPTIBILITY GENE ; BODY ; RISK ; GENE ; ENZYMES ; DISEASE ; lung cancer ; LUNG-CANCER ; PATIENT ; MECHANISM ; DNA ; TUMORS ; validation ; DRUG ; RNA ; GENES ; THERAPY ; VITRO ; LUNG ; COMBINATION ; CANCER ; EXPRESSION ; IN-VITRO ; CELLS ; CELL ; tumor ; AGENTS ; radiotherapy ; NSCLC ; CANCER-RISK ; cancer research ; RNA EXPRESSION ; ENZYME ; case control studies ; analysis ; GENOTYPE ; PROFILES ; single-nucleotide ; development ; PROMOTER POLYMORPHISM ; XRCC1 ; VARIANT ; WEIGHT ; SINGLE NUCLEOTIDE POLYMORPHISMS ; SNPs ; case-control study ; GEMCITABINE ; CAPACITY ; DEFICIENCY ; small cell lung cancer ; AGENT ; SINGLE ; DNA repair ; MPO ; APE1
    Abstract: Cells in the body are permanently attacked by DNA-reactive species, both from intracellular and environmental sources. Inherited and acquired deficiencies in host defense mechanisms against DNA damage (metabolic and DNA repair enzymes) can modify cancer susceptibility as well as therapy response. Genetic profiles should help to identify high-risk individuals who subsequently can be enrolled in preventive measures or treated by tailored therapy regimens. Some of our attempts to define such risk profiles are presented. Cancer susceptibility: Single nucleotide polymorphisms (SNPs) in metabolic and repair genes were investigated in a hospital-based lung cancer case-control study. When evaluating the risk associated with different genotypes for N-acetyltransferases (Wikman et al. 2001) and glutathione-S-transferases (Risch et al. 2001), it is mandatory to distinguish between the three major histological subtypes of lung tumors. A promoter polymorphism of the myeloperoxidase gene MPO was shown to decrease lung cancer susceptibility mainly in small cell lung cancer (SCLC) (Dally et al. 2002). The CYP3A4*1B allele was also linked to an increased SCLC risk and in smoking women increased the risk of lung cancer eightfold (Dally et al. 2003b). Polymorphisms in DNA repair genes were shown to modulate lung cancer risk in smokers, and reduced DNA repair capacity elevated the disease risk (Rajaee-Behbahani et al. 2001). Investigations of several DNA repair gene variants revealed that lung cancer risk was only moderately affected by a single variant but was enhanced up to approximately threefold by specific risk allele combinations (Popanda et al. 2004). Therapy response: Inter-individual differences in therapy response are consistently observed with cancer chemotherapeutic agents. Initial results from ongoing studies showed that certain polymorphisms in drug transporter genes (ABCB1) differentially affect response outcome in histological subgroups of lung cancer. Stronger beneficial effects were seen in non-small cell lung cancer (NSCLC) patients following gemcitabine and in SCLC patients following etoposide-based treatment. Several DNA repair parameters (polymorphisms, RNA expression, and DNA repair capacity) were measured in vitro in lymphocytes of patients before radiotherapy and correlated with the occurrence of acute side effects (radio-hypersensitivity). Our initial analysis of several repair gene variants in breast cancer patients (n = 446) who received radiotherapy revealed no association of single polymorphisms and the development of side effects (moist desquamation of the irradiated normal skin). The risk for this side effect was, however, strongly reduced in normal weight women carrying a combination of XRCC1 399Gln and APE1 148Glu alleles, indicating that these variants afford some protection against radio-hypersensitivity (Chang-Claude et al. 2005). Based on these data we conclude that specific metabolic and DNA repair gene variants can affect cancer risk and therapy outcome. Predisposition to hereditary cancer syndromes is dominated by the strong effects of some high-penetrance tumor susceptibility genes, while predisposition to sporadic cancer is influenced by the combination of multiple low-penetrance genes, of which as a major challenge, many disease-relevant combinations remain to be identified. Before translating these findings into clinical use and application for public health measures, large population-based studies and validation of the results will be required.
    Type of Publication: Book chapter
    Signatur Availability
    BibTip Others were also interested in ...
  • 7
    facet.materialart.
    facet.materialart.
    Wiley VCH
    Keywords: GENES ; TUMORS ; GENE ; tumor
    Type of Publication: Book chapter
    Signatur Availability
    BibTip Others were also interested in ...
  • 8
    Keywords: Rb ; PKB/AKT ; lipid ; mechanism of action ; erufosine ; synergistic combinations ; pAkt ; BCR-ABL ; CML ; caspases ; KINASE INHIBITOR ; LEVEL ; INCREASE ; SUBSTRATE ; AGENT ; signaling ; CASPASE ; INHIBITORS ; protein expression ; MAMMALIAN-CELLS ; PROTEIN-KINASE-C ; leukemia ; FUSION ; LINE ; MEMBRANE ; SIGNAL-TRANSDUCTION ; COMPONENT ; ALKYLPHOSPHOCHOLINES ; ANTILEUKEMIC EFFICACY ; CELL-LINE ; chemotherapy ; cell lines ; p27 ; ENTRY ; HEALTH ; ASSAY ; PROGRESSION ; SIGNAL ; treatment ; TYROSINE KINASE INHIBITOR ; CYCLE ; CELL-LINES ; CELL-CYCLE ; cell cycle ; PROTEIN-KINASE ; signal transduction ; INDUCTION ; REDUCTION ; TYROSINE KINASE ; COMBINATION ; KINASE ; PATHWAY ; THERAPY ; PATHWAYS ; CELL ; INHIBITOR ; APOPTOSIS ; EXPRESSION ; CELLS ; DISEASE ; NEW-YORK ; LINES ; cell line ; DRUG ; PROTEINS ; PROTEIN ; TRANSDUCTION ; cell signaling ; MECHANISM ; PATIENT
    Abstract: The ether lipid analog erufosine (erucylphospho-N,N,N,- trimethylpropylammonium, ErPC3) has high activity against leukemic cells without affecting the normal hematopoiesis. It belongs to the group of alkylphosphocholines (APC) that are inhibitors of protein kinase C and phospholipase C. However, the mechanism of action of erufosine remains rather unclear. We focused on combination effects with the tyrosine kinase inhibitor imatinib mesylate (gleevec, former STI-571 or CGP-57148) against two chronic myeloid leukemia (CML)-derived cell lines (K-562 and BV-173). The influence of erufosine on proteins involved in the phosphatidylinositol-3-phosphate pathway and on expression of the retinoblastoma protein Rb was studied, the latter being a key component for cell cycle entry and progression in mammalian cells. The consecutive treatment of K-562 and BV-173 cells with erufosine (2.5, 5, 15, 30 mu M) and imatinib mesylate (0.05, 0.1 mu M) led to synergism as measured by the MTT-dye reduction assay and this is reason to hypothesize that such combinations could be beneficial for relapsed patients with drug-resistant disease. Whole cell lysates from K-562 and BV-173 were investigated for the expression of Rb, PKB/Akt, pAkt, and p27 by Western blot. Erufosine caused decreases of pAkt and CML fusion protein p210 (BCR-ABL) protein expression, but induced the Rb protein expression in K-562 cells. A parallel increase in p27 level was observed after 24 and 48 h treatment. These alterations in signal transduction could be an explanation for the drug interaction found. Furthermore, Rb is a substrate of caspases and is cleaved during apoptosis as already evidenced for BV-173 cells. Our experimental findings suggest that erufosine acts through induction of changes in protein signaling and especially through Rb induction. This unique mode of action makes it an attractive partner for combination therapies, for example, in combination with imatinib mesylate for treatment of CML
    Type of Publication: Book chapter
    Signatur Availability
    BibTip Others were also interested in ...
  • 9
    Keywords: PATIENT ; MRI ; MAGNETIC-RESONANCE ; MULTIPLE-MYELOMA ; BODIES ; multiple myeloma ; MEDICINE ; MONOCLONAL GAMMOPATHY ; UNDETERMINED SIGNIFICANCE ; monoclonal gammopathy of undetermined significance ; INTERNATIONAL-SOCIETY
    Type of Publication: Proceeding
    Signatur Availability
    BibTip Others were also interested in ...
  • 10
    Keywords: perfusion MRI ; cancer research ; SEQUENCE ; MRI ; PATIENT ; CANCER ; PERFUSION ; MAGNETIC-RESONANCE ; PROTOCOL
    Abstract: In this work a real-time saturation recovery pulse sequence is used to monitor a superselective hepatic embolisation. To assess embolisation-induced perfusion changes, time-resolved FLASH data sets are acquired before and after the embolisation. Compared to conventional MR-guided embolisation in X/MR-suites this procedure does not require patient re-psoitioning and is thus significantly faster.
    Type of Publication: Proceeding
    Signatur Availability
    BibTip Others were also interested in ...
  • 11
    Keywords: REQUIREMENT ; ACCURATE ; GUIDANCE ; TRACKING ; MAGNETIC-RESONANCE ; MR ; TIME ; PATIENT ; CANCER ; COMBINATION ; Germany ; INTERVENTIONS ; Application ; TIMES ; RANGE ; cancer research
    Abstract: The increasing complexity of MR-guided interventions demands high SNR and short image acquisition times. Therefore, a rising number of such procedures is performed in closed-bore MR scanners where patient access is severely restricted. Consequently, safe, accurate, and continuous instrument monitoring and guidance is a mandatory pre-requisite. A combination of an automatic passive tracking technique and a manually steerable instrument holder is proposed to meet the requirements of percutaneous interventions. The setup was tested during LITT as an advanced minimally invasive technique. Our experiments demonstrate the potential of this approach which is suitable for a wide range of interventional applications.
    Type of Publication: Proceeding
    Signatur Availability
    BibTip Others were also interested in ...
  • 12
    Keywords: TIME ; PATIENT ; SURGERY ; ACCURACY ; imaging ; CLASSIFICATION ; CANCER ; Germany ; SERIES ; SELECTION ; sensitivity ; tumour ; EXPERIENCE ; LESIONS ; magnetic resonance imaging ; MAGNETIC-RESONANCE ; rectal cancer ; prospective study ; predictive value ; ACCURATE ; COIL ; prospective ; analysis ; ultrasound ; staging
    Type of Publication: Book chapter
    Signatur Availability
    BibTip Others were also interested in ...
  • 13
    Keywords: MEMORY ; virus ; ACTIVATION ; PATIENT ; CELLS ; CANCER ; SURVIVAL ; tumor ; TUMOR-CELLS ; THERAPY ; human ; PATIENT SURVIVAL ; HUMAN CANCER ; HUMAN CANCERS
    Type of Publication: Book chapter
    Signatur Availability
    BibTip Others were also interested in ...
  • 14
  • 15
    Keywords: PET ; nuclear medicine ; PEPTIDES ; PEPTIDE ; THERAPY ; DIAGNOSIS ; NUCLEAR-MEDICINE ; PATIENT ; THERAPIES ; monitoring ; molecular ; NUCLEAR ; GA-68-DOTATOC ; therapy monitoring ; MEDICINE
    Type of Publication: Book chapter
    Signatur Availability
    BibTip Others were also interested in ...
  • 16
    Keywords: PART ; ONCOLOGY ; radiation therapy ; RADIATION ONCOLOGY ; RADIATION-THERAPY ; radiation ; PATIENT ; THERAPY
    Type of Publication: Book chapter
    Signatur Availability
    BibTip Others were also interested in ...
  • 17
    Keywords: CELLS ; EXPRESSION ; CELL ; Germany ; PATHWAY ; PATHWAYS ; ACETATE-NONUTILIZING MUTANTS ; CDNA ; CDNA CLONES ; CLONES ; CLONING ; CRASSA ; DISTINCT ; DNA-microarray analysis,transcriptional profiling,correspondence analysis,acetate metabolism,Neurosp ; ENZYMES ; FILAMENTOUS FUNGUS ; GENE ; GENE-EXPRESSION ; GENES ; GENOME ; GENOME SEQUENCE ; HYBRIDIZATION ; microarray ; NMT1 ; PROTEIN ; PROTEINS ; RNA ; SACCHAROMYCES-CEREVISIAE ; SAMPLE ; SAMPLES ; transcription
    Abstract: Nutrient-dependent variations in transcript levels of the filamentous fungus Neurospora crassa were studied on a microarray containing some 4700 cDNAs. Cells were grown in minimal and acetate medium. The isolated RNA was analyzed in comparison to the results obtained upon the hybridization of samples prepared from the RNA of cells grown in full medium. Altogether, 160 cDNA clones exhibited significant variations, falling into five distinct subgroups of very similar transcription profiles. This is indicative of the occurrence of a high degree of co-regulation of genes in N. crassa. Especially the regulation of the expression of proteins involved in metabolic pathways was found to be strongly regulated at the RNA level. (C) 2003 Elsevier Inc. All rights reserved
    Type of Publication: Journal article published
    PubMed ID: 14599890
    Signatur Availability
    BibTip Others were also interested in ...
  • 18
    Keywords: evaluation ; SUPPORT ; SYSTEM ; SYSTEMS ; Health Technology Assessment ; IMIA Yearbook ; medical informatics ; PATIENT ; quality of health care
    Abstract: Objectives: The Yearbook of Medical Informatics is published annually by the International Medical Informatics Association (IMIA) and contains a selection of excellent papers on medical informatics research which have been recently published (http://www.yearbook.uni-hd.de). The 2003 Yearbook of Medical Informatics took as its theme the role of medical informatics for the quality of health care. In this paper, we will discuss challenges for health care, and the lessons learned from editing IMIA Yearbook 2003. Results and Conclusions: Modern information processing methodology and information and communication technology have strongly influenced our societies and health care. As a consequence of this, medicallion- formatics as a discipline has taken a leading role in the further development of health care. This involves developing information systems that enhance opportunities for global access to health services and medical knowledge. Informatics methodology and technology will facilitate high quality of care in aging societies, and will decrease the possibilities of health care errors. It will also enable the dissemination of the latest medical and health information on the web to consumers and health care providers alike. The selected papers of the IMIA Yearbook 2003 present clear examples and future challenges, and they highlight how various sub-disciplines of medical informatics can contribute to this
    Type of Publication: Journal article published
    PubMed ID: 12743656
    Signatur Availability
    BibTip Others were also interested in ...
  • 19
    Keywords: measurement ; Germany ; PERFUSION ; QUANTIFICATION ; LONG-TERM ; PIGS ; validation ; TIME ; PATIENT ; kidney ; SERA ; ACUTE REJECTION ; ALLOGRAFT SURVIVAL ; BLOOD-FLOW ; DONOR ; GRAFT ; HEPATIC MICROCIRCULATION ; IMPACT ; INDEX ; intraoperative ; LIVER-TRANSPLANTATION ; MICROCIRCULATION ; pig ; primary ; prognosis ; QUALITY ; REDUCTION ; renal ; renal function ; RENAL-FUNCTION ; REPERFUSION ; RISK-FACTORS ; TRANSPLANTATION
    Abstract: Background. We evaluated the significance of perioperative cortical microperfusion for graft function and long-term prognosis after renal allotransplantation. Thermodiffusion technology was clinically applied for the first time, after previous validation for perfusion monitoring of the renal cortex in pigs. Methods. A thermodiffusion probe was inserted into the renal cortex in 30 transplant recipients after graft reperfusion. Real-time measurements were recorded until the end of the operation. In 14 patients perfusion was measured daily until postoperative day 7. Microcirculation was correlated to serum creatinine level, scintigraphic findings, and long-term outcome. Results. In primary graft function, intraoperative perfusion was 85 7 mL/100 g per min compared with significantly lower values in cases with subsequent graft dysfunction. The best discrimination was defined for a level of 70 mL/100 g per min with a positive predictive value of 88% for detection of good graft function and 86% for nonfunction. Intraoperative perfusion was significantly different in patients with normal grafts, delayed function, and graft loss. Postoperatively, lower perfusion was found in acute tubular necrosis; a significant correlation could be noted between microcirculation and perfusion index measured by nuclear scanning (r=0.78, P〈0.01). Living-related grafts were characterized by higher intraoperative perfusion and superior graft quality. Conclusion. Thermodiffusion could be clinically applicable for the perioperative monitoring of renal graft perfusion. Intraoperative reduction of cortical microcirculation has a high predictive value with respect to detection of delayed renal function. Postoperatively, impaired renal microperfusion is associated with acute tubular necrosis. Living-related donor grafts show less microcirculatory alteration than cadaveric kidneys
    Type of Publication: Journal article published
    PubMed ID: 12717202
    Signatur Availability
    BibTip Others were also interested in ...
  • 20
    Keywords: EXPRESSION ; INHIBITOR ; Germany ; KINASE ; GENE ; GENES ; PROTEIN ; SACCHAROMYCES-CEREVISIAE ; transcription ; COMPONENTS ; COMPLEX ; COMPLEXES ; cell cycle ; CELL-CYCLE ; CYCLE ; protein kinase ; PROTEIN-KINASE ; IDENTIFICATION ; gene expression ; protein kinase CK2 ; Saccharomyces cerevisiae ; SUBUNIT ; YEAST ; BUDDING YEAST ; DISRUPTION ; EXPRESSION ANALYSIS ; HOLOENZYME ; PHO pathway
    Abstract: The budding yeast Saccharomyces cerevisiae encounters phosphate starvation by the transcription-regulated PHO pathway. We find that genetic perturbation of protein kinase CK2, a conserved tetrameric Ser/Thr phosphotransferase with links to cell cycle and transcription, affects expression of PHO pathway genes in a subunit- and isoform-specific manner. Remarkably, the genes encoding phosphate supplying phosphatases and transporters are significantly repressed, while the genes encoding components of the central pathway regulator complex, a cyclin-dependent kinase (CDK), a cyclin, and a CDK inhibitor, remain unaltered. Thus, perturbation of CK2 uncouples the executive part of the PHO pathway from its cyclin-CDK control complex. (C) 2003 Published by Elsevier Science B.V. on behalf of the Federation of European Biochemical Societies
    Type of Publication: Journal article published
    PubMed ID: 12606059
    Signatur Availability
    BibTip Others were also interested in ...
  • 21
    Keywords: EXPRESSION ; screening ; DISTINCT ; GENE ; GENES ; GENOME ; DNA ; FAMILY ; ASSOCIATION ; autistic disorder,susceptibility gene,chromosome 2,mutation screening,association ; CANDIDATE GENE ; chromosome ; DISORDER ; DLX GENES ; FREQUENCY ; GENOMEWIDE SCREEN ; GENOMIC SCREEN ; GLUTAMIC-ACID DECARBOXYLASE ; LINKAGE ; polymorphism ; POLYMORPHISMS ; SIGNAL ; single nucleotide polymorphism ; SUSCEPTIBILITY ; SUSCEPTIBILITY GENES ; SUSCEPTIBILITY LOCUS ; VARIANTS
    Abstract: The results from several genome scans indicate that chromosome 2q21-q33 is likely to contain an autism susceptibility locus. We studied the potential contribution of nine positional and functional candidate genes: TBR-1; GAD1; DLX1; DLX2; cAMP-GEFII; CHN1; ATF2; HOXD1 and NEUROD1. Screening these genes for DNA variants and association analysis using intragenic single nucleotide polymorphisms did not provide evidence for a major role in the aetiology of autism. Four rare nonsynonymous variants were identified, however, in the cAMP-GEFII gene. These variants were present in five families, where they segregate with the autistic phenotype, and were not observed in control individuals. The significance of these variants is unclear, as their low frequency in IMGSAC families does not account for the relatively strong linkage signal at the 2q locus. Further studies are needed to clarify the contribution of cAMP-GEFII gene variants to autism susceptibility
    Type of Publication: Journal article published
    PubMed ID: 14593429
    Signatur Availability
    BibTip Others were also interested in ...
  • 22
    Keywords: CANCER ; PROTECTION ; MODEL ; DISEASE ; EPIDEMIOLOGY ; HISTORY ; RISK ; GENE ; GENES ; SAMPLE ; FAMILY ; RISK-FACTORS ; SUSCEPTIBILITY ; BREAST ; breast cancer ; BREAST-CANCER ; AGE ; BRCA1 ; case-only design ; family history ; gene carrier probability ; LINKAGE ANALYSIS ; mixture logistic model ; ovarian cancer ; OVARIAN-CANCER ; population and sibling controls ; WOMEN
    Abstract: Background The effect of environmental/lifestyle factors on breast cancer risk may be modified by genetic predisposition. Methods In a population-based case-control-family study performed in Germany including 706 cases by age 50 years, 1381 population, and 252 sister controls, we investigated main effects for environmental/lifestyle factors and genetic susceptibility and gene-environment interaction (G x E). Different surrogate measures for genetic predisposition using pedigree information were used: first-degree family history of breast or ovarian cancer; and gene carrier probability using a genetic model based on rare dominant genes. Possible G x E interaction was studied by (1) logistic regression using cases and population controls including an interaction term; (2) comparing results using sister controls and population controls; (3) case-only analysis with logistic regression and (4) a mixture logistic model. Results Familial predisposition showed the strongest main effect and the estimated gene carrier probability gave the best fit. High parity and longer duration of breastfeeding reduced breast cancer risk significantly, a history of abortions increased risk and age at menarche showed no significant effect. We found significant G x E interaction between parity and genetic susceptibility using different surrogate measures. In women most likely to have a high genetic susceptibility, high parity was less protective. Later age at menarche was protective in women with a positive family history. No evidence for G x E interaction was found for breastfeeding and abortion. Conclusions These findings corroborate results from other studies and provide further evidence that the magnitude of protection from parity is reduced in women most likely to have a genetic risk in spite of the limitations of using surrogate genetic measures
    Type of Publication: Journal article published
    PubMed ID: 12690006
    Signatur Availability
    BibTip Others were also interested in ...
  • 23
    Keywords: CLINICAL-TRIAL ; Germany ; SAMPLE ; PATIENT ; DESIGN ; CLINICAL-TRIALS ; chemotherapy ; RECRUITMENT ; CENTERS ; clinical trial : randomized,multi-center,design,hypotheses,significance,sample size ; III COLON-CANCER ; study design
    Abstract: In discussing design and results of randomized clinical trials, in particular with clinical oncologists, one often encounters the opinion that a phase III trial is a complicated, highly costly, and difficult task. Part of this opinion seems to originate in myths around underlying biostatistical principles such as randomization, sampling and sample size, statistical hypotheses, statistical error probabilities, and statistical power. This work clarifies basic statistical issues of randomized clinical trials and the interpretation of their results. Six issues ('myths') relevant for the design of clinical trials and the interpretation of their results are addressed. They concern choice of study design, choice of participating centers, and recruitment of patients as well as statistical questions of establishing study hypotheses and interpreting p values. These myths are shown to be caused primarily through a misunderstanding of statistical inference and statistical thinking that can be avoided when a rational understanding of statistical principles is translated into a clinical research approach. We also conclude that before clinical evidence is summarized from different studies each study should be examined thoroughly
    Type of Publication: Journal article published
    PubMed ID: 14709929
    Signatur Availability
    BibTip Others were also interested in ...
  • 24
    Keywords: Germany ; LUNG ; PERFUSION ; imaging ; VENTILATION ; DIFFERENTIATION ; RESOLUTION ; PATIENT ; IMPACT ; image analysis ; MR ; MRI ; SEQUENCE ; SIGNAL ; MAGNETIC-RESONANCE ; magnetic resonance imaging ; ACQUISITION ; REQUIRES ; SCINTIGRAPHY ; ABNORMALITIES ; acquisitions (GRAPPA) ; ANGIOGRAPHY ; CONTRAST-ENHANCED MRI ; generalized autocalibrating partially parallel ; magnetic resonance imaging (MRI) ; parallel imaging techniques ; PULMONARY PERFUSION
    Abstract: Rationale: Contrast-enhanced magnetic resonance imaging (MRI) of lung perfusion requires a high spatial and temporal resolution. Partially parallel MRI offers an improved spatial and temporal resolution. Objective: To assess the feasibility of partially parallel MRI for the assessment of lung perfusion. Methods: Two healthy volunteers and 14 patients were examined with a contrast-enhanced 3D gradient-echo pulse sequence with partially parallel image acquisitions (TE/TR/alpha: 0.8/1.9 milliseconds/40degrees; voxel size 3.6 X 2.0 X 5.0 mm(3), TA: 1.5 seconds). The image analysis included an analysis of the signal-to-noise ratio in the lungs in areas with normal and impaired perfusion. 3D MR perfusion image data were analyzed for perfusion defects and compared with radionuclide perfusion scans, which were available for 10 of 14 patients. Results: The analysis of the 3D perfusion-weighted data allowed a clear differentiation of perfusion abnormalities: MRI showed normal lung perfusion in 9 of 16 cases, whereas perfusion abnormalities were observed in 7 cases. When compared with the radionuclide perfusion scans, a good intermodality agreement was shown (kappa = 0.74). When compared with normally perfused lung a significantly lower signal to noise ratio was observed in hypoperfused lung (7 versus 17; P = 0.02). Conclusion: Partially parallel MRI might be used for the assessment of lung perfusion. Future studies are required to further evaluate the diagnostic impact of this technique
    Type of Publication: Journal article published
    PubMed ID: 12874514
    Signatur Availability
    BibTip Others were also interested in ...
  • 25
    Keywords: COMBINATION ; evaluation ; ALGORITHM ; VOLUME ; ACCURACY ; SURGERY ; TIME ; PATIENT ; DONOR ; intraoperative ; BODY-WEIGHT ; MR ; FIELD ; MAGNETIC-RESONANCE ; DISPLAY ; arteries ; MR-ANGIOGRAPHY ; magnetic resonance angiography ; ANOMALIES ; contrast-enhanced magnetic resonance angiography ; CT ANGIOGRAPHY ; DIGITAL SUBTRACTION ANGIOGRAPHY ; DIGITAL-SUBTRACTION-ANGIOGRAPHY ; gadobenate dimeglumine ; KIDNEY DONORS ; maximum intensity projection ; MAXIMUM-INTENSITY-PROJECTION ; pathology ; renal angiography ; shaded-surface display ; TRANSPLANT DONORS ; UROGRAPHY ; volume rendering
    Abstract: The aim of this study was to assess the value of contrast- enhanced three-dimensional MR angiography (CE 3D MRA) in the preoperative assessment of potential living renal donors, and to compare the accuracy for the depiction of the vascular anatomy using three different rendering algorithms. Twenty- three potential living renal donors were examined with CE 3D MRA (TE/TR=1.3 ms/3.7 ms, field of view 260-320x350 mm, 384- 448x512 matrix, slab thickness 9.4 cm, 72 partitions, section thickness 1.3 rum, scan time 24 s, 0.1 mmol/kg body weight gadobenate dimeglumine). Magnetic resonance angiography data sets were processed with maximum intensity projection (MIP), volume rendering (VR), and shaded-surface display (SSD) algorithms. The image analysis was performed independently by three MR-experienced radiologists recording the number of renal arteries, the presence of early branching or vascular pathology. The combination of digital subtraction angiography (DSA) and intraoperative findings served as the gold standard for the image analysis. In total, 52 renal arteries were correspondingly observed in 23 patients at DSA and surgery. Other findings were 3 cases of early branching of the renal arteries, 4 cases of arterial stenosis and I case of bilateral fibromuscular dysplasia. With MRA source data all 52 renal arteries were correctly identified by all readers, compared with 51 (98.1%), 51-52 (98.1-100%) and 49-50 renal arteries (94.2-96.2%) with the MIP, VR and SSD projections, respectively. Similarly, the sensitivity, specificity and accuracy was highest with the MRA source data followed by MIP, VR and SSD. Time requirements were lowest for the MIP reconstructions and highest for the VR reconstructions. Contrast-enhanced 3D MRA is a reliable, non-invasive tool for the preoperative evaluation of potential living renal donors. Maximum intensity projection is favourable for the processing of 3D MRA data, as it has minimal time and computational requirements, while having similar or superior accuracy for the depiction of vessel anomalies or pathology compared with VR and SSD, respectively
    Type of Publication: Journal article published
    PubMed ID: 12664119
    Signatur Availability
    BibTip Others were also interested in ...
  • 26
    facet.materialart.
    facet.materialart.
    Internist 44 (9), 1131-1139 
    Keywords: Germany ; THERAPY ; COMMON ; DIAGNOSIS ; DISEASE ; NEW-YORK ; POPULATION ; RISK ; TIME ; PATIENT ; NEPHRITIS ; INFECTION ; GRAFT ; renal ; STAGE ; IDENTIFICATION ; PROGRESSION ; EXPERIENCE ; RISK FACTOR ; RECURRENCE ; FREQUENT ; CLINICAL-FEATURES ; CLINICALLY-RELEVANT ; CYCLOPHOSPHAMIDE ; FAILURE ; glomerulonephritis ; HYPERTENSION ; INFECTIONS ; NATURAL-HISTORY ; NEPHROPATHY ; PREDICTORS ; PREVALENCE ; proteinuria ; RECURRENT ; renal insufficiency ; renoparenchymal hypertension ; RISK GROUP ; STAGE RENAL-FAILURE
    Abstract: IgA nephropathy (IgAN) is the most common type of glomerulonephritis in the western world. In the majority of cases, it manifests in adolescence or early adulthood as recurrent macrohematuria, frequently triggered by infections, or persistent microhematuria as well as mild proteinuria, hypertension and/or renal insufficiency. In view of the later, it is not surprising that IgAN is often a chance finding. The majority of affected persons probably never come to medical attention, since in autopsies a prevalence of up to 1% of the population has been reported. About 20-30% of patients with a diagnosis of IgAN suffer from chronic, slowly progressive renal failure. Predictors include the degree of proteinuria and arterial hypertension as well as the established renal impairment at the time of diagnosis. Early identification of this risk group is of particular importance, since adequate therapy can stop or at least retard the progression of renal failure. When end stage renal failure has developed and a renal transplant is performed, about 25% of the patients will experience a clinically relevant recurrence of IgAN with progressive graft dysfunction
    Type of Publication: Journal article published
    Signatur Availability
    BibTip Others were also interested in ...
  • 27
    Keywords: SURVIVAL ; tumor ; Germany ; INHIBITION ; MODEL ; MODELS ; DISEASE ; DISEASES ; incidence ; liver ; RISK ; SITE ; SITES ; GENE ; TUMORS ; STORAGE ; TIME ; PATIENT ; NITRIC-OXIDE SYNTHASE ; INJURIES ; DNA ; INFECTION ; RISK-FACTORS ; CARCINOGENESIS ; RAT ; RATS ; PROTEIN-KINASE ; treatment ; virus ; prevention ; STRESS ; risk factors ; metastases ; DAMAGE ; chemoprevention ; COLON CARCINOGENESIS ; copper toxicity ; curcumin ; ETHENO-DNA ADDUCTS ; HEREDITARY HEPATITIS ; LEC rats ; LIPID-PEROXIDATION ; MOUSE FIBROBLAST CELLS ; NIH 3T3 ; ORNITHINE DECARBOXYLASE ; OXIDATIVE STRESS
    Abstract: Long-Evans Cinnamon (LEC) rats, an inbred mutant strain which accumulates copper due to an aberrant copper-transporting ATPase gene, develop acute hepatitis, chronic liver injury and liver tumors as a result of copper-induced oxidative stress, lipid peroxidation and DNA damage. Curcumin, an antioxidant and anti-inflammatory agent, has shown anticancer properties in many rodent models. We investigated the modulating role of curcumin in liver and kidney carcinogenesis in LEC rats. Two groups of 4-week-old LEC rats (n = 60 each) were fed either a standard diet (control) or received 0.5% curcumin in the diet for life. In untreated LEC rats, the rate of acute liver failure, the incidence of liver tumors and of kidney tumors were 32, 100 and 10% respectively, which was not altered by curcumin treatment. However, curcumin reduced tumor incidence at other organ sites (15% versus 0%; P = 0.025) and suppressed formation of metastases (18% versus 0%; P = 0.01). Median survival time was decreased from 88.7 to 78.1 weeks in curcumin-treated rats (P = 0.002). The lack of chemoprevention of liver and kidney tumors in LEC rats by curcumin may be caused by enhanced toxicity and oxidative stress due to excess copper. We conclude that curcumin should be contra-indicated for patients suffering from inherited and acquired metal storage diseases that include patients with hepatitis C virus infection. (C) 2002 Elsevier Science B.V. All rights reserved
    Type of Publication: Journal article published
    PubMed ID: 12628510
    Signatur Availability
    BibTip Others were also interested in ...
  • 28
    Keywords: EXPRESSION ; Germany ; QUANTIFICATION ; TIME ; PATIENT ; treatment ; ALPHA ; ASSAY ; DECREASE ; POLYMERASE-CHAIN-REACTION ; INTERFERON
    Abstract: We developed a real-time quantitative polymerase chain reaction-based assay for quantification of PRV-1 mRNA. We found that the expression of PRV-1 in granulocytes of patients with polycythemia vera (PV) who were pretreated with phlebotomy or hydroxyurea was significantly higher than that in normal controls. Surprisingly, in PV patients who had received interferon-alpha (IFN) for five or more months no significant PRV-1 upregulation was found. Observation of four PV patients treated with IFN over six months revealed a uniform time- dependent decrease of initially upregulated PRV-1
    Type of Publication: Journal article published
    PubMed ID: 12651277
    Signatur Availability
    BibTip Others were also interested in ...
  • 29
    Keywords: CANCER ; EXPRESSION ; carcinoma ; CELL ; Germany ; human ; LUNG ; lung cancer ; LUNG-CANCER ; EXPOSURE ; RISK ; GENE ; PROTEIN ; METABOLISM ; TISSUE ; PATIENT ; RISK-FACTORS ; FREQUENCY ; polymorphism ; SUSCEPTIBILITY ; PROMOTER ; OVARIAN-CANCER ; WOMEN ; MEN ; risk factors ; smoking ; PROSTATE-CANCER ; cancer risk ; RISK FACTOR ; CYP3A4 ; LINKAGE DISEQUILIBRIUM ; CANCER-PATIENTS ; CARCINOMAS ; POLYMERASE-CHAIN-REACTION ; adenocarcinoma ; ADENOCARCINOMAS ; CARRIERS ; case-control studies ; CLINICAL PRESENTATION ; CYP3A,genetic polymorphism,lung cancer susceptibility,small cell lung cancer,LightCycler ; EXPRESSED HUMAN CYTOCHROME-P450S ; GENETIC VARIANT ; HUMAN LIVER-MICROSOMES ; PROSTATE TUMORS ; PROTEIN LEVELS ; squamous cell carcinoma ; TOBACCO
    Abstract: CYP3A isozymes are involved in tobacco carcinogen- and steroid-metabolism, and are expressed in human lung tissue showing interindividual variation in expression and activity. The CYP3A4* 1 B allele has been associated with a two-fold higher promoter activity and with high-grade prostate cancers. The very frequent intron 3 polymorphism in the CYP3A5 gene (CYP3A5*3) results in decreased CYP3A5 protein levels. A case-control study was conducted in 801 Caucasian lung cancer patients that included 330 adenocarcinomas, 260 squamous cell carcinomas, 171 small cell lung cancers (SCLC) and 432 Caucasian hospital-based controls. CYP3A-genotyping was performed by capillary polymerase chain reaction followed by fluorescence-based melting curve analysis. A significantly increased SCLC risk for CYP3A4* 1B allele carriers [odds ratio (OR) 2.25, 95% confidence interval (CI) 1.11-4.55, P = 0.02] was found. After dividing cases and controls by gender, an increased lung cancer risk for CYP3A4* 1B carriers (OR 3.04, 95% CI 0.94-9.90, P= 0.06) for women but not for men (OR 1.00, 95% CI 0.56-1.81) was revealed. Heavier smoking men (greater than or equal to 20 pack-years) with the CYP3A4* 1 B allele had a significant OR for lung cancer of 3.42 (95% CI 1.65-7.14, P= 0.001) compared to * 1A/1* 1A carriers with lower tobacco exposure (〈 20 pack-years). For women, the respective OR was 8.00 (95% CI 2.12-30.30, P = 0.005). Genotype frequencies were generally in Hardy-Weinberg equilibrium, except for CYP3A5 where a greater than expected number of CYP3A5* 1 homozygotes was observed among cases (P = 0.006). In addition, we observed linkage disequilibrium of CYP3A4 and CYP3A5 (P 〈 0.00001), but a nonsignificantly increased lung cancer risk was only found for homozygous CYP3A5* 1 allele carriers (OR 5.24,95% CI 0.85-102.28, P = 0.14) but not for heterozygotes. To confirm our observation that the CYP3A4* 1B allele increases SCLC risk and modifies the smoking-related lung cancer risk in a gender-specific manner, further studies, including CYP3A haplotype analysis, will be necessary. Pharmacogenetics 13:607-618 (C) 2003 Lippincott Williams Wilkins
    Type of Publication: Journal article published
    PubMed ID: 14515059
    Signatur Availability
    BibTip Others were also interested in ...
  • 30
    Keywords: CANCER CELLS ; CELLS ; EXPRESSION ; tumor ; carcinoma ; CELL ; Germany ; human ; DISEASE ; NEW-YORK ; DISTINCT ; GENE ; GENE-EXPRESSION ; GENES ; microarray ; RNA ; cell line ; TISSUE ; validation ; LINES ; MARKER ; TISSUES ; tumour ; CELL-LINES ; BREAST-CANCER ; TARGET ; immunohistochemistry ; gene expression ; affymetrix ; CELL-LINE ; LINE ; MARKERS ; CARCINOMAS ; adenocarcinoma ; OVEREXPRESSION ; PERIPHERAL-BLOOD ; GASTRIC-CANCER ; ADAM9 ; CDNA MICROARRAYS ; cell lines ; expression profiling ; HUMAN GENES ; K-RAS ; METALLOPROTEASE-DISINTEGRIN ; microarray hybridisation ; microdissection ; OLIGONUCLEOTIDE ARRAYS ; pancreatic cancer ; pancreatic carcinoma ; SERIAL ANALYSIS
    Abstract: In a search for new molecular markers of pancreatic ductal adenocarcinoma (PDAC), we compared the gene expression profiles of seven pancreatic carcinomas and one carcinoma of the papilla Vateri with those of duct cells from three non-neoplastic pancreatic tissues. In addition, the human pancreatic duct cell line and five PDAC cell lines (AsPC-1, BxPC-3, Capan-1, Capan-2, HPAF) were examined. RNA was extracted from microdissected tissue or cultured cell lines and analysed using a custom-made Affymetrix Chip containing 3023 genes, of which 1000 were known to be tumour associated. Hierarchical clustering revealed 81 differentially expressed genes. Of all the genes, 26 were downregulated in PDAC and 14 were upregulated in PDAC. In PDAC cell lines versus normal pancreatic duct cells, 21 genes were downregulated and 20 were upregulated. Of these 81 differentially expressed genes, 15 represented human genes previously implicated in the tumourigenesis of PDAC. From the genes that were so far not known to be associated with PDAC tumorigenesis, we selected ADAM9 for further validation because of its distinct overexpression in tumour tissue. Using immunohistochemistry, the over-expressed gene, ADAM9, was present in 70% of the PDACs analysed. In conclusion, using microarray technology we were able to identify a set of genes whose aberrant expression was associated with PDAC and may be used to target the disease
    Type of Publication: Journal article published
    PubMed ID: 12942322
    Signatur Availability
    BibTip Others were also interested in ...
  • 31
    Keywords: CANCER ; BLOOD ; DISEASE ; RISK ; GENE ; PROTEIN ; SAMPLES ; PATIENT ; DNA ; FAMILY ; FREQUENCY ; BREAST ; BREAST-CANCER ; family history ; OVARIAN-CANCER ; WOMEN ; MUTATION ; MUTATIONS ; PREVALENCE ; BRCA1/2 ; BRCA2 MUTATIONS ; early-onset breast cancer ; German population ; germline mutations ; POPULATION-BASED SAMPLE
    Abstract: This study was undertaken to investigate the prevalence of BRCA1 and BRCA2 germline mutations in 91 German patients unselected for family history, who were diagnosed with breast cancer before the age of 41 years. Clinical information and blood samples were obtained from all patients. A comprehensive BRCA1 and BRCA2 mutational analysis was performed using the protein truncation assay and single-strand conformational polymorphism analysis followed by DNA sequencing of variant signals detected by these assays. Five different deleterious germline mutations including four frameshift mutations and one missense mutation were identified, three in BRCA1 (3.3%) and two mutations (2.2%) in BRCA2. Both BRCA2 mutations are novel and might be specific for the German population. An additional BRCA1 missense mutation previously described and classified as an unknown variant was found. This mutation was also detected in two breast cancer patients of family P 328 and not in 140 healthy controls suggesting that it is disease associated. In addition, one common polymorphism and five novel intronic sequence variants with unknown significance were found. Our findings show that mutations in BRCA1 and BRCA2 may contribute similarly to early-onset breast cancer in Germany. Given current constraints on health-care resources, these results support the notion that BRCA1 and BRCA2 mutation screening may have the strongest impact on health-care when targeted to high- risk populations
    Type of Publication: Journal article published
    PubMed ID: 12774040
    Signatur Availability
    BibTip Others were also interested in ...
  • 32
    Keywords: GROWTH ; tumor ; Germany ; MORTALITY ; NEW-YORK ; RISK ; PROTEIN ; PATIENT ; TUMOR-NECROSIS-FACTOR ; INTERVENTION ; treatment ; PLASMA ; DECREASE ; AGE ; MUSCLE ; AMINO-ACIDS ; OXIDATIVE STRESS ; ANTIOXIDANT ; aging-related wasting ; ALPHA-LIPOIC ACID ; antioxidants and aging ; cysteine ; ELDERLY HUMANS ; INJURIOUS FALLS ; MUSCLE PROTEIN-SYNTHESIS ; muscular aging ; P70 S6 KINASE ; PLASMA REDOX STATE ; RAT SKELETAL-MUSCLE ; RESISTANCE EXERCISE ; role in aging ; tumor necrosis factor in aging
    Abstract: Aging-related loss of muscle function is a predictor of mortality and a surrogate parameter of the aging process. Its consequences include a high risk for falls, hip fractures, and loss of autonomy. Aging is associated with changes in the oxidant/antioxidant balance including a decrease in plasma thiol (cysteine) concentration. To assess the importance of cysteine, we determined in a double-blind study the effects of N-acetylcysteine on the functional capacity of frail geriatric patients and their response to physical exercise. The subjects on placebo showed only a relatively weak response, and 31% showed even a decrease in more than one parameter during the observation period. Low plasma arginine levels were correlated with a weak overall performance before exercise and a poor response to exercise. N-Acetyl-cysteine strongly enhanced the increase in knee extensor strength and significantly increased the sum of all strength parameters if adjusted for baseline arginine level as a confounding parameter. N-acetylcysteine had no significant effect on growth hormone and IGF-1 levels but caused a significant decrease in plasma TNF-alpha. These findings may provide a basis for therapeutic intervention and suggest that the loss of function involves limitations in cysteine and one or more other amino acids which may compromise muscular protein synthesis
    Type of Publication: Journal article published
    PubMed ID: 12601528
    Signatur Availability
    BibTip Others were also interested in ...
  • 33
    Keywords: SURVIVAL ; COMBINATION ; evaluation ; Germany ; THERAPY ; FOLLOW-UP ; SURGERY ; TIME ; PATIENT ; primary ; CYCLE ; treatment ; ALPHA ; TRIAL ; DIFFERENCE ; METASTASIS ; chemotherapy ; MELANOMA ; PROGNOSTIC-FACTORS ; HIGH-RISK ; PROGNOSTIC FACTORS ; IMMUNOTHERAPY ; FOLLOW-UP TIME ; MALIGNANT-MELANOMA ; INTERFERON ; CENTERS ; MELANOMA PATIENTS ; CUTANEOUS MELANOMA ; RANDOMIZED TRIAL ; ADJUVANT ; DACARBAZINE ; DOSE BOLUS INTERLEUKIN-2 ; IL-2 ; PROGNOSTIC FACTOR ; RANDOMIZED-TRIAL ; RECOMBINANT INTERLEUKIN-2 ; relapse
    Abstract: Purpose: Low-dose interferon alfa (IFNalpha) has been shown to have limited effects in the adjuvant treatment of patients with intermediate- and high-risk primary melanoma. We hypothesized that a combination regimen with low-dose interleukin-2 (IL-2) may improve survival prospects in these patients. Patients and Methods: After wide excision of primary melanoma without clinically detectable lymph node metastasis (pT3 to 4, cN0, M0), 225 patients from 10 participating centers were randomly assigned to receive either subcutaneous low-dose 1FNalpha2b (3 million international units [MU]/m(2)/d, days 1 to 7, week 1; three times weekly, weeks 3 to 6, repeated all 6 weeks) plus IL-2 (9 MU/m(2)/d, days 1 to 4, week 2 of each cycle) for 48 weeks, or observation alone. The primary end point was prolongation of a relapse-free interval. Results: Of the 225 enrolled patients, 223 were found to be eligible. Median follow-up time was 79 months. All evaluated prognostic factors were well balanced between the two arms of the study. Relapses were noticed in 36 of 113 patients treated with IFNalpha2b plus IL-2 and in 34 of 110 patients with observation alone. Five-year disease-free survival of those who had routine surgery supplemented by IFNalpha2b and IL-2 treatment was 70.1% (95% confidence interval [CI], 61.3% to 78.9%), compared with 69.9% in those receiving surgery and observation alone (95% CI, 60.7% to 79.1%) in the intention-to-treat analysis. Evaluation of the overall survival did not show any difference between treated and untreated melanoma patients (P = .93). Conclusion: Adjuvant treatment of intermediate- and high-risk melanoma patients with low-dose IFNalpha2b and IL-2 is safe and well tolerated by most patients, but it does not improve disease-free or overall survival
    Type of Publication: Journal article published
    PubMed ID: 12885805
    Signatur Availability
    BibTip Others were also interested in ...
  • 34
    Keywords: tumor ; carcinoma ; Germany ; THERAPY ; NEW-YORK ; TISSUE ; PATIENT ; MICROCIRCULATION ; primary ; prognosis ; MRI ; SIGNAL ; MAGNETIC-RESONANCE ; DECREASE ; metastases ; MAMMOGRAPHY ; EXCHANGE ; PARAMETERS ; tomography ; CERVICAL-CARCINOMA ; SQUAMOUS-CELL CARCINOMA ; HEAD ; pharmacokinetic ; dynamic magnetic resonance tomography,tissue microcirculation,diagnostic parameter,advanced oro-hypo ; NECK TUMORS ; SONOGRAPHY ; TUMOR ANGIOGENESIS ; VASCULARITY
    Abstract: Purpose. With the help of dynamic magnetic resonance tomography (dMRT) the status of tissue microcirculation can be visualized.Methods. Dynamic MRI was performed in 13 patients with advanced, nonresectable oro- or hypopharynx carcinoma at the beginning and the end of therapy. Maximal signal intensity and exchange rate constant in the tissue of the tumor and the lymph node metastases were analyzed using a pharmacokinetic two-compartment model.Results. In all six patients with clinical complete response (CR), the maximal signal intensity increased after therapy in the tissue of the primary tumor and the lymph node metastases. Furthermore, a high decrease in the parameter k(21) was associated with a better prognosis and could be observed especially after combined radiochemotherapy.Conclusion. Our first results indicate that contrast-enhanced dynamic MRI studies before and after radio- or combined radiochemotherapy offer important information about the changes of microcirculation in the tissue of the tumor and lymph node metastases. Furthermore, this information seems to be a promising predictor for clinical outcome of therapy
    Type of Publication: Journal article published
    PubMed ID: 14605706
    Signatur Availability
    BibTip Others were also interested in ...
  • 35
    Keywords: FOLLOW-UP ; LUNG-CANCER ; CANCER MORTALITY ; DISEASE ; RISK ; RISKS ; WORKERS ; TIME ; PATIENT ; RISK-FACTORS ; AGE ; MEN ; risk factors ; RATES ; SWEDEN ; DATABASE ; SIR ; INCIDENCE RATES ; FAMILY-CANCER DATABASE ; ASBESTOS ; ASBESTOS EXPOSURE ; EUROPE ; MALIGNANT MESOTHELIOMA ; REFINERY/PETROCHEMICAL PLANT COHORTS
    Abstract: Epidemiologic data on pleural mesothelioma are scarce on regional and occupational time trends, which would monitor the effects of changes in exposure to asbestos. We aim to characterize time trends, regional, socioeconomic, and occupational risk factors for pleural mesothelioma in Sweden in the years from 1961 to 1998. The Swedish Family-Cancer Database was used to identify patients with pleural mesothelioma. Age- standardized incidence rates and standardized incidence ratio (SIR) were calculated for the population in the Database. A total of 1298 male and 233 female pleural mesotheliomas were retrieved. Age-standardized incidence of the disease was highest, and the trend increased in residents of large industrial and shipbuilding cities. In the last follow-up period, the male rate exceeded the female rate about 10-fold. Among male socioeconomic groups, manual workers showed the highest and ever-increasing SIR. No female socioeconomic group was at risk. For men, plumbers and seamen had the highest risk of 4.56 and 2.83, respectively, but the risks appeared to be decreasing for plumbers, whereas no clear trend was noted for seamen, probably because of indirect expose in ships. Farmers showed an SIR of 0.28, indicating that the population at large was at four times higher risk than farmers. The SIRs of many academic/college-educated groups were two to six times higher than those of farmers, suggesting indirect exposure to asbestos in these groups
    Type of Publication: Journal article published
    PubMed ID: 12708150
    Signatur Availability
    BibTip Others were also interested in ...
  • 36
    Keywords: CANCER ; carcinoma ; SYSTEM ; HEPATOCELLULAR-CARCINOMA ; incidence ; liver ; POPULATION ; RISK ; RISKS ; GENE ; GENES ; FAMILY ; primary ; tumour ; MEMBER ; MEMBERS ; ASSOCIATION ; CANDIDATE GENE ; SUSCEPTIBILITY ; AGE ; ovarian cancer ; OVARIAN-CANCER ; CERVICAL-CANCER ; bladder cancer ; BLADDER-CANCER ; SWEDEN ; DATABASE ; SIR ; familial risk ; CARRIERS ; FAMILY-CANCER DATABASE ; bile duct ; BILE-DUCTS ; CHOLECYSTECTOMY ; GALLBLADDER-CANCER ; RELATIVES ; VIRAL-HEPATITIS
    Abstract: Background and aims: Familial risks in liver and biliary cancers have been assessed in small case control studies, usually based on reported, but not medically verified, cancers in family members. Thus the degree of familial clustering for these cancers remains to be established. Methods: The nationwide Swedish Family-Cancer Database was used, covering 10.2 million individuals for the years 1961-1998 from the Swedish Cancer Registry. Liver and biliary tract cancers were identified from 1121 offspring between the ages of 0 and 66 years and 17 131 parents. Standardised incidence ratios (SIRs) and 95% confidence intervals (Cls) were calculated for cancers in family members. Results: All cancers in the liver and biliary system showed a familial SIR of 1.65 (95% Cl 1.05- 2.46). This was mainly explained by a high risk for familial gall bladder cancer (SIR 5.21 (95% Cl 2.07-10.80)) and for familial primary liver cancer with hepatocellular carcinoma histology (SIR 4.69 (95% Cl 1.48-11.04)). For gall bladder and hepatocellular cancer, maternal transmission appeared to be favoured. Gall bladder cancer was associated with pancreatic cancer (SIR 2.39 (95% Cl 1.23-4.18)). Primary liver cancer was associated with cervical, urinary bladder, and endocrine gland tumours. Cancer in extrahepatic bile ducts was associated with ovarian cancer and that in ampulla of Vater with thyroid cancer; however, these associations may have been fortuitous. Conclusions: This study has provided the first data on familial clustering of liver and gall bladder cancers, based on medically confirmed records. The risks were so high that heritable factors were likely to contribute, possibly modified by environmental factors. The demonstration of candidate genes would help to further characterise the familial risks
    Type of Publication: Journal article published
    Signatur Availability
    BibTip Others were also interested in ...
  • 37
    Keywords: CANCER ; neoplasms ; THERAPY ; DISEASE ; incidence ; RISK ; RISKS ; SITE ; SITES ; PATIENT ; primary ; SKIN ; LYMPHOMA ; MALIGNANCIES ; skin cancer ; MELANOMA ; SWEDEN ; DATABASE ; SQUAMOUS-CELL CARCINOMA ; SIR ; PRIMARY CANCERS ; FAMILY-CANCER DATABASE ; 2ND PRIMARY NEOPLASMS ; CANCER-THERAPY ; immunological factors ; immunosuppression ; LONG-TERM SURVIVORS ; MULTIPLE PRIMARY CANCERS ; non-hodgkin's lymphoma ; second cancer ; therapeutic effects
    Abstract: Successes in cancer therapy have led to increasing numbers of cancer survivors, who are at risk of developing second primary cancers. Therapy- or disease-induced suppression of the immune function may predispose cancer patients to a second malignancy. An excess of squamous cell skin cancers (SCC) and non-Hodgkin's lymphomas has been found in immunosuppressed patients. We used the nationwide Swedish Family-Cancer Database on 10.2 million individuals to calculate the risk of second primary skin cancers and non-Hodgkin's lymphomas following a previous malignancy. A total of 4301 second skin cancers and 1672 non- Hodgkin's lymphomas were identified. Standardised incidence ratios (SIR)s and 95% Confidence Intervals (CIs) were calculated and compared. Among 14 different sites for male or